These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Low-dose fibrinolytics and glycoprotein IIb/IIIa receptor blockade for the treatment of acute myocardial infarction. Ferrario M; Repetto A; Lucreziotti S; Ardissino D Am Heart J; 1999 Aug; 138(2 Pt 2):S121-5. PubMed ID: 10426870 [No Abstract] [Full Text] [Related]
7. Clinical trials with glycoprotein IIb/IIIa receptor antagonists in acute coronary syndromes. Van de Werf F Thromb Haemost; 1997 Jul; 78(1):210-3. PubMed ID: 9198155 [TBL] [Abstract][Full Text] [Related]
8. The evolving role of platelet glycoprotein IIb/IIIa inhibitors in the management of acute coronary syndromes. Stringer KA Ann Pharmacother; 1999 Jun; 33(6):712-22. PubMed ID: 10410186 [TBL] [Abstract][Full Text] [Related]
9. Controversies surrounding platelet glycoprotein IIb/IIIa inhibitors in percutaneous coronary intervention and acute coronary syndromes. Harrington RA Semin Thromb Hemost; 2004 Dec; 30(6):639-47. PubMed ID: 15630670 [TBL] [Abstract][Full Text] [Related]
10. Primary stenting and glycoprotein IIb/IIIa inhibitors in acute myocardial infarction. Colombo A; Briguori C Am Heart J; 1999 Aug; 138(2 Pt 2):S153-7. PubMed ID: 10426875 [TBL] [Abstract][Full Text] [Related]
13. An Updated Review on Glycoprotein IIb/IIIa Inhibitors as Antiplatelet Agents: Basic and Clinical Perspectives. Sharifi-Rad J; Sharopov F; Ezzat SM; Zam W; Ademiluyi AO; Oyeniran OH; Adetunji CO; Roli OI; Živković J; Martorell M; Docea AO; El Omari N; Bouyahya A; Lorenzo JM; Calina D High Blood Press Cardiovasc Prev; 2023 Mar; 30(2):93-107. PubMed ID: 36637623 [TBL] [Abstract][Full Text] [Related]
14. Glycoprotein IIb/IIIa platelet receptor inhibitors: a new dimension in cardiology. Tan HC Ann Acad Med Singap; 1997 Jul; 26(4):481-8. PubMed ID: 9395815 [TBL] [Abstract][Full Text] [Related]
15. Effect of glycoprotein IIb-IIIa receptor antagonism on platelet membrane glycoproteins after coronary stent placement. Gawaz M; Ruf A; Neumann FJ; Pogátsa-Murray G; Dickfeld T; Zohlnhöfer D; Schömig A Thromb Haemost; 1998 Dec; 80(6):994-1001. PubMed ID: 9869173 [TBL] [Abstract][Full Text] [Related]
16. An overview of the results of clinical trials with glycoprotein IIb/IIIa inhibitors. Adgey AA Eur Heart J; 1998 Apr; 19 Suppl D():D10-21. PubMed ID: 9597518 [TBL] [Abstract][Full Text] [Related]
17. Antiplatelet drugs. A comparative review. Schrör K Drugs; 1995 Jul; 50(1):7-28. PubMed ID: 7588091 [TBL] [Abstract][Full Text] [Related]
18. Prospective use of platelet glycoprotein IIb/IIIa receptor blockers in the emergency department setting. Gibler WB; Wilcox RG; Bode C; Castaigne AD; Delooz H; Elich D; Fox KA; Kereiakes DJ; Rupprecht H; Topol EJ Eur J Emerg Med; 1998 Dec; 5(4):391-402. PubMed ID: 9919443 [TBL] [Abstract][Full Text] [Related]
20. Advancing the battle against acute ischemic syndromes: a focus on the GP IIb-IIIa inhibitors. Dobesh PP; Latham KA Pharmacotherapy; 1998; 18(4):663-85. PubMed ID: 9692642 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]